ADME Study of [14C]-Jaktinib in Healthy Male Subjects

Clinical trial NCT05150717 · COMPLETED

Trial details

NCT number: NCT05150717
Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Adult Male Volunteers

Start date: 2022-01-04
Primary completion: 2022-01-30
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.